首页> 外国专利> Compounds derived from quinazolinona tetrahydro -, Tank and parp-1 inhibitors; Preparation Process; Drugs; Pharmaceutical Kit, use in the treatment and / or prevention of cancer, multiple sclerosis, cardiovascular disease, central nervous system injury.

Compounds derived from quinazolinona tetrahydro -, Tank and parp-1 inhibitors; Preparation Process; Drugs; Pharmaceutical Kit, use in the treatment and / or prevention of cancer, multiple sclerosis, cardiovascular disease, central nervous system injury.

机译：衍生自四氢喹唑啉酮，Tank和parp-1抑制剂的化合物;制备过程;毒品;药物试剂盒，用于治疗和/或预防癌症，多发性硬化症，心血管疾病，中枢神经系统损伤。

页面导航

摘要
著录项
相似文献

摘要

Compounds of the formula I in which U, V and W have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

机译：其中U，V和W具有权利要求1中所指含义的式I化合物为Tankyrase的抑制剂，并可尤其用于治疗疾病，例如癌症，心血管疾病，中枢神经系统损伤和不同形式的炎症。

著录项

公开/公告号CL2014002097A1

专利类型
公开/公告日2014-11-07

原文格式PDF
申请/专利权人 MERCK PATENT GMBH;
展开▼

申请/专利号CL20140002097
发明设计人 LEUTHNER BIRGITTA;BUCHSTALLER HANS-PETER;ESDAR CHRISTINA;
展开▼

申请日2014-08-07
分类号A61K31/517;A61P25;A61P35;C07D239/95;C07D401/04;C07D401/12;
国家 CL
入库时间 2022-08-21 15:58:26

相似文献

专利
外文文献
中文文献